Login / Signup

Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.

Danielle S WallaceChris RowlandBrian T HillAndrea M BaranCarla CasuloPatrick M ReaganAllison M WinterReem KarmaliJane N WinterLeo I GordonAndrew BuiPeter SportelliHari P MiskinMichael S WeissJonathan W FriedbergShuo MaPaul M Barr
Published in: Leukemia & lymphoma (2023)
Keyphrases
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • chronic lymphocytic leukemia